Clin2
NCT07675629Likely a fitNot yet recruiting

HIV vaccine safety study for healthy adults

HIV Prevention

Part of Infections clinical trials.

This trial tests an experimental HIV vaccine to see if it is safe and triggers an immune response. It is for healthy adults who are HIV-negative and at low risk for HIV.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
126 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in good general health, with no major medical conditions.
  • You are HIV-negative and willing to get HIV tests and counseling.
  • You are not pregnant or breastfeeding, and if you were born female, you agree to use effective birth control during the study.
  • You have not received an HIV vaccine before.
  • You are willing to avoid other investigational drugs or vaccines during the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06796686Recruiting· Phase 1
HIV vaccine safety and immune response study for healthy adults

This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.

San Francisco, California
NCT07390474Recruiting· Phase 1
HIV vaccine safety and immune response study for healthy adults

This study tests two experimental mRNA-based HIV vaccines to see if they are safe and create an immune response. It is for healthy adults aged 18 to 55 who do not have HIV.

Atlanta, Georgia
NCT06617091Recruiting· Phase 1
HIV vaccine trial for healthy adults with and without HIV

This trial tests an experimental HIV vaccine in healthy adults, including those living with HIV. The goal is to see if the vaccine is safe and prompts an immune response.

Mtubatuba, KwaZulu-Natal
NCT06205056Recruiting· Phase 1
HIV vaccine safety and immune response test

This trial tests a new combination HIV vaccine in healthy adults to see if it is safe and produces an immune response. If you are at low risk for HIV, you may help researchers learn more about future prevention strategies.

Kampala
NCT07390955Recruiting· Phase 1
Safety study of three anti-HIV antibodies in healthy adults

This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.

Birmingham, Alabama
NCT07757802Recruiting· Phase 1
HIV vaccine nanoparticle and mRNA booster for healthy adults

This study tests a new HIV vaccine that uses tiny particles (nanoparticles) and an mRNA booster — similar to some COVID vaccines. The goal is to see if it is safe and helps your body fight HIV. It's for healthy adults who do not have HIV.

San Francisco, California

Hear when a new HIV Prevention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.